Kuantum Papers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 5, 2025, 4:15 pm

Quick Insight

Kuantum Papers Ltd, operating in the Paper & Paper Products industry, currently trades at ₹131, reflecting a market capitalization of ₹1,145 crore. The company's price-to-earnings (P/E) ratio of 9.94 suggests it is undervalued compared to industry peers, particularly given its robust return on equity (ROE) of 9.86% and return on capital employed (ROCE) of 11.1%. With an operating profit margin (OPM) of 22% and a solid interest coverage ratio (ICR) of 7.90x, the firm demonstrates strong operational efficiency. Despite a high promoter holding of 70.31%, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) remain largely absent, indicating potential for increased interest. With reserves of ₹1,204 crore against borrowings of ₹654 crore, Kuantum appears well-positioned for growth, making it a compelling candidate for investors seeking value

Competitors of Kuantum Papers Ltd

All Competitor Stocks of Kuantum Papers Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:38 am

Below is a detailed analysis of the quarterly data for Kuantum Papers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 277.00 Cr.. The value appears strong and on an upward trend. It has increased from 270.00 Cr. (Dec 2024) to 277.00 Cr., marking an increase of 7.00 Cr..
• For Expenses, as of Mar 2025, the value is 217.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 220.00 Cr. (Dec 2024) to 217.00 Cr., marking a decrease of 3.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Dec 2024) to 60.00 Cr., marking an increase of 10.00 Cr..
• For OPM %, as of Mar 2025, the value is 22.00%. The value appears strong and on an upward trend. It has increased from 19.00% (Dec 2024) to 22.00%, marking an increase of 3.00%.
• For Other Income, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Dec 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 10.00 Cr..
• For Depreciation, as of Mar 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Dec 2024) to 15.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Dec 2024) to 36.00 Cr., marking an increase of 8.00 Cr..
• For Tax %, as of Mar 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Dec 2024) to 28.00%, marking an increase of 2.00%.
• For Net Profit, as of Mar 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Dec 2024) to 26.00 Cr., marking an increase of 5.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.99. The value appears strong and on an upward trend. It has increased from 2.40 (Dec 2024) to 2.99, marking an increase of 0.59.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:29 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:49 am

Below is a detailed analysis of the balance sheet data for Kuantum Papers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,204.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,115.00 Cr. (Mar 2024) to 1,204.00 Cr., marking an increase of 89.00 Cr..
• For Borrowings, as of Mar 2025, the value is 654.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 512.00 Cr. (Mar 2024) to 654.00 Cr., marking an increase of 142.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 246.00 Cr.. The value appears to be improving (decreasing). It has decreased from 251.00 Cr. (Mar 2024) to 246.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,113.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,888.00 Cr. (Mar 2024) to 2,113.00 Cr., marking an increase of 225.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,620.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,475.00 Cr. (Mar 2024) to 1,620.00 Cr., marking an increase of 145.00 Cr..
• For CWIP, as of Mar 2025, the value is 155.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2024) to 155.00 Cr., marking an increase of 113.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 338.00 Cr.. The value appears to be declining and may need further review. It has decreased from 371.00 Cr. (Mar 2024) to 338.00 Cr., marking a decrease of 33.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,113.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,888.00 Cr. (Mar 2024) to 2,113.00 Cr., marking an increase of 225.00 Cr..

Notably, the Reserves (1,204.00 Cr.) exceed the Borrowings (654.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Kuantum Papers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 21.07. This value is within the healthy range. It has increased from 15.60 (Mar 23) to 21.07, marking an increase of 5.47.
• For Diluted EPS (Rs.), as of Mar 24, the value is 21.07. This value is within the healthy range. It has increased from 15.60 (Mar 23) to 21.07, marking an increase of 5.47.
• For Cash EPS (Rs.), as of Mar 24, the value is 26.59. This value is within the healthy range. It has increased from 20.81 (Mar 23) to 26.59, marking an increase of 5.78.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 128.79. It has increased from 110.79 (Mar 23) to 128.79, marking an increase of 18.00.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 128.79. It has increased from 110.79 (Mar 23) to 128.79, marking an increase of 18.00.
• For Dividend / Share (Rs.), as of Mar 24, the value is 3.00. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 3.00, marking an increase of 3.00.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 138.81. It has decreased from 150.07 (Mar 23) to 138.81, marking a decrease of 11.26.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 38.81. This value is within the healthy range. It has decreased from 43.87 (Mar 23) to 38.81, marking a decrease of 5.06.
• For PBIT / Share (Rs.), as of Mar 24, the value is 33.28. This value is within the healthy range. It has decreased from 38.66 (Mar 23) to 33.28, marking a decrease of 5.38.
• For PBT / Share (Rs.), as of Mar 24, the value is 28.37. This value is within the healthy range. It has increased from 23.26 (Mar 23) to 28.37, marking an increase of 5.11.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 21.07. This value is within the healthy range. It has increased from 15.60 (Mar 23) to 21.07, marking an increase of 5.47.
• For PBDIT Margin (%), as of Mar 24, the value is 27.96. This value is within the healthy range. It has decreased from 29.23 (Mar 23) to 27.96, marking a decrease of 1.27.
• For PBIT Margin (%), as of Mar 24, the value is 23.97. This value exceeds the healthy maximum of 20. It has decreased from 25.76 (Mar 23) to 23.97, marking a decrease of 1.79.
• For PBT Margin (%), as of Mar 24, the value is 20.44. This value is within the healthy range. It has increased from 15.49 (Mar 23) to 20.44, marking an increase of 4.95.
• For Net Profit Margin (%), as of Mar 24, the value is 15.17. This value exceeds the healthy maximum of 10. It has increased from 10.39 (Mar 23) to 15.17, marking an increase of 4.78.
• For Return on Networth / Equity (%), as of Mar 24, the value is 16.35. This value is within the healthy range. It has increased from 14.08 (Mar 23) to 16.35, marking an increase of 2.27.
• For Return on Capital Employeed (%), as of Mar 24, the value is 18.31. This value is within the healthy range. It has decreased from 22.78 (Mar 23) to 18.31, marking a decrease of 4.47.
• For Return On Assets (%), as of Mar 24, the value is 9.73. This value is within the healthy range. It has increased from 8.05 (Mar 23) to 9.73, marking an increase of 1.68.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.27. This value is within the healthy range. It has decreased from 0.34 (Mar 23) to 0.27, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.45. This value is within the healthy range. It has decreased from 0.49 (Mar 23) to 0.45, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.67. It has decreased from 0.77 (Mar 23) to 0.67, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 24, the value is 1.02. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 23) which recorded 1.02.
• For Quick Ratio (X), as of Mar 24, the value is 0.64. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 23) to 0.64, marking an increase of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.55. This value is below the healthy minimum of 4. It has decreased from 4.50 (Mar 23) to 3.55, marking a decrease of 0.95.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 14.24. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 14.24, marking an increase of 14.24.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 11.28. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 11.28, marking an increase of 11.28.
• For Earning Retention Ratio (%), as of Mar 24, the value is 85.76. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 85.76, marking an increase of 85.76.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 88.72. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 88.72, marking an increase of 88.72.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 7.90. This value is within the healthy range. It has increased from 5.39 (Mar 23) to 7.90, marking an increase of 2.51.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 5.29. This value is within the healthy range. It has increased from 3.81 (Mar 23) to 5.29, marking an increase of 1.48.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,786.29. It has increased from 1,555.37 (Mar 23) to 1,786.29, marking an increase of 230.92.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.47. This value is within the healthy range. It has increased from 1.19 (Mar 23) to 1.47, marking an increase of 0.28.
• For EV / EBITDA (X), as of Mar 24, the value is 5.27. This value is within the healthy range. It has increased from 4.06 (Mar 23) to 5.27, marking an increase of 1.21.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.12. This value is within the healthy range. It has increased from 0.80 (Mar 23) to 1.12, marking an increase of 0.32.
• For Retention Ratios (%), as of Mar 24, the value is 85.75. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 85.75, marking an increase of 85.75.
• For Price / BV (X), as of Mar 24, the value is 1.20. This value is within the healthy range. It has increased from 1.10 (Mar 23) to 1.20, marking an increase of 0.10.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.12. This value is within the healthy range. It has increased from 0.80 (Mar 23) to 1.12, marking an increase of 0.32.
• For EarningsYield, as of Mar 24, the value is 0.13. This value is below the healthy minimum of 5. It has increased from 0.12 (Mar 23) to 0.13, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness